Skip to main content
SpringerLink
Log in

Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review

  • Conference paper
Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics

Abstract

The introduction of radioimmunoassay (RIA) methods in the early 1960s permitted accurate measurement of individual pituitary hormones (Laron 1969) and the diagnosis of various types of pituitary insufficiency (Laron 1981a). It soon became possible not only to deflne a disease entity such as isolated human pituitary growth hormone (hGH) deficiency but also to diagnose partial defects and transitory deficiencies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abramovici A, Josefsberg Z, Mimouni M, Liban E, Laron Z (1983) Histopathological features of the skin in hypopituitarism in Laron type dwarfism. Israel J Med Sei

    Google Scholar 

  • Adam A, Josefsberg Z, Pertzelan A, Zadik Z, Chemke JM, Laron Z (1981) Occurrence of four types of growth hormone related dwarfism in Israeli communities. Eur J Pediatr 137: 35–39

    Article  PubMed  CAS  Google Scholar 

  • Alcaniz JJ, Salto L, Barcelo B (1978) GH secretion in two siblings wiht Laron’s dwarfism: the effects of glucose, arginine, somatostatin and bromoeryptine. J Clin Endocrinol Metab 47: 453–456

    Article  PubMed  CAS  Google Scholar 

  • Anderson WF, Fletcher JD (1980) Gene therapy in human beings: when is it ethical to begin? N Engl J Med 303: 1293–1296

    Article  PubMed  CAS  Google Scholar 

  • Arad I, Laron Z (1979) Standards for upper/lower body segment ratio/sitting height — sub-ischial leg length from birth to 18 years in girls and boys. In: Proceedings of Ist International Congress of Auxology, Rome. Centro Auxologica Italiano di Piancavallo, Milan, pp 159-164

    Google Scholar 

  • Carr B, Friesen HG (1976) Growth hormone and insulin binding to human liver J Endocrinol Metab 42: 484–493

    CAS  Google Scholar 

  • Clemons RD, Costing G, Kogut MD (1976) Laron dwarfism: growth and immunore-active insulin following treatment with human growth hormone. J Pediatr 88: 427–433

    Article  PubMed  CAS  Google Scholar 

  • Collado F, Martull MV, Torreblanca J, Fernandez A (1971) Enanismo familiar con niveles altos de hormona de crescimento ( GH) y falta de respuesta periferica a la hormona de crescimento humana exogena (hGH) y a la testosterona. Bol S Ped Madr 18: 7–16

    Google Scholar 

  • Daughaday WH (1981) Growth hormone and the somatomedins. In: Daughaday WH (ed) Endocrine control of growth. Elsevier, North Holland, New York Oxford, pp 1–24

    Google Scholar 

  • Daughaday WH, Laron Z, Pertzelan A, Heins JN (1969) Defective sulfation factor generation: a possible etiological link in dwarfism. Trans Assoc Am Physicians 82: 129–138

    PubMed  CAS  Google Scholar 

  • Eiders MJ, Garland JT, Daughaday A, Fisher DA, Whitney JE, Hughes ER (1973) Laron’s dwarfism: studies on the nature of the defect. J Pediatr 83: 253–263

    Article  Google Scholar 

  • Eshet R, Laron Z, Brown M, Arnon R (1973) Immunoreactive properties of the plasma hGH from patients with the Syndrome of familial dwarfism and high plasma IR-hGH. J Clin Endocrinol Metab 37: 819–821

    Article  PubMed  CAS  Google Scholar 

  • Eshet R, Laron Z, Brown M, Arnon R (1974) Immunological behaviour of hGH from plasma of patients with familial dwarfism and high IR-hGH in a radioimmunoassay system using the cross reaction between hGH and HCS. Horm Metab Res 6: 80–81

    Article  PubMed  CAS  Google Scholar 

  • Eshet R, Peleg S, Josefsberg Z, Laron Z (1981) Characterization of hGH from patients with LTD by a human liver radioreceptor assay (RRA) ( Abstr ). Pediatr Res 15: 89

    Google Scholar 

  • Eshet R, Laron Z, Pertzelan A, Arnon R, Dintzman M (in press) Defect of hGH receptors in the liver of 2 patients with Laron type dwarfism. Isr J Med Sei

    Google Scholar 

  • Frankel JJ, Laron Z (1968) Psychological aspects of pituitary insufficiency in children and adolescents with special reference to growth hormone. Isr J Med Sei 4:953–961

    CAS  Google Scholar 

  • Frasier SD, Smith FG Jr (1966) Antibodies to human growth hormone. Development during therapy with human growth hormone. Am J Dis Child 112: 383–388

    Google Scholar 

  • Galatzer A, Rosenblith E, Laron Z (1978) Psychological and rehabilitation aspects of short stature and delayed puberty. In: Gedda L, Parisi P (eds) Auxology: Human growth in health and disorder. Academic Press, London, pp 303 — 311

    Google Scholar 

  • Golde DW, Bersch N, Kaplan SA, Rimoin DL, Li CH (1980) Peripheral unresponsiveness to human growth hormone in Laron dwarfism. N Engl J Med 303: 1156–1159

    Article  PubMed  CAS  Google Scholar 

  • Goodman AD,Tanenbaum R, Rabinowitz D (1972) Existence of two forms of immunoreactive growth hormone in human plasma. J Clin Endocrinol Metab 35: 868–878

    Article  Google Scholar 

  • Jacobs LS, Sneid DS, Garland JT, Laron Z, Daughaday WH (1976) Receptor active growth hormone in Laron dwarfism. J Clin Endocrinol Metab 42: 403–406

    Article  PubMed  CAS  Google Scholar 

  • Rastrup KW, Andersen H, Hanssen KF (1975) Increased immunoreactive plasma and urinary growth hormone in growth retardation with defective generation of somatomedin A ( Laron’s Syndrome ). Acta Paediatr Scand 64: 613–618

    Google Scholar 

  • Kleine TO, Merten B, Meier HW, Nevo Z, Kowadlo Silbergeld A, Mamet R, Laron Z (1980) Effect of normal and pathological sera of patients with low serum somatomedin levels on prteoglycan glycosaminoglyean biosynthesis in two types of cartilage. In: Robert AM, Robert L (eds) Biochimie des tissue conjonctifs normaux et pathologiques. CNRS Editions, Paris, pp 173–175

    Google Scholar 

  • Konfino R, Pertzelan A, Laron Z (1975) Cephalometric measurements of familial dwarfism and high plasma immunoreactive growth hormone. Am J Orthod 68: 196–201

    Article  PubMed  CAS  Google Scholar 

  • Laron Z (1969) The hypothalamus and the pituitary gland (hypophysis). In: Hubble DW (ed) Paediatric endocrinology, Blackwell, Oxford, pp 35–111

    Google Scholar 

  • Laron Z (1974) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone. Isr J Med Sei 10: 1247–1253

    CAS  Google Scholar 

  • Laron Z (1977) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone (IR-hGH) — Laron type dwarfism. Paediatrician 6: 106–117

    Google Scholar 

  • Laron Z (1981a) Clinical aspects of pituitary dwarfism and related conditions. In: Daughaday WH (ed) Endocrine control of growth. Elsevier, North Holland, New York, pp 175–205

    Google Scholar 

  • Laron Z (1981b) Nutrition and growth factors with special emphasis on proteins. In: Beers RF, Bassett EG (eds) Nutritional factors: Modulating effects on metabolic Processes, Raven Press, New York, pp 337–354

    Google Scholar 

  • Laron Z (1982) Somatomedin, insulin, growth hormone and growth. Isr J Med Sei 18: 823–829

    CAS  Google Scholar 

  • Laron Z, Galatzer A (1980) Aspects of brain development in children and adolescents with pituitary growth hormone deficiency. In: De Wied D, Van Keep PA (eds) Hormones and the brain. MTP Press, Lancaster, pp 293–302

    Chapter  Google Scholar 

  • Laron Z, Karp M (1980) Carbohydrate metabolism in the Syndrome of familial and high plasma immunoreactive growth hormone (Laron type dwarfism). In: Podolsky S, Viswanathan M (eds) Secondary diabetes: The spectrum of the diabetic Syndrome. Raven Press, New York, pp 363–371

    Google Scholar 

  • Laron Z, Pertzelan A, Mannheimer S (1966) Genetic pituitary dwarfism with high serum concentration of growth hormone. A new inborn error of metabolism? Isr J Med Sei 2: 152–155

    CAS  Google Scholar 

  • Laron Z, Karp M, Dudek M, Kowadlo Silbergeld A, Harel D (1968a) A contribution to the fat mobilizing activity of human growth hormone. Helv Paediatr Acta 23: 37–44

    PubMed  CAS  Google Scholar 

  • Laron Z, Pertzelan A, Karp M (1968b) Pituitary dwarfism with high serum levels of growth hormone. Isr J Med Sei 4: 883–894

    CAS  Google Scholar 

  • Laron Z, Pertzelan A, Karp M, Kowadlo Silbergeld A, Daughaday WH (1971) Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone. Measurement of sulfation factor, metabolic and linear growth responses. J Clin Endocrinol Metab 33: 332–342

    Google Scholar 

  • Laron Z, Karp M, Pertzelan A, Kauli R, Keret R, Doron M (1972) The Syndrome of familial dwarfism and high plasma immunoreactive human growth hormone (IR-hGH). In: Pecile A, Muller EE (eds) Growth and growth hormone. Exceprta Medica, Amsterdam, pp 458–482

    Google Scholar 

  • Laron Z, Doron M, Josefsberg Z, Klonizky S, Weissman I (1974) Plasma glucagon response to arginine infusion in children with isolated hGH deficiency, panhypopituitarism and familial dwarfism and high plasma IR-hGH deficiency. In: Luft R, Yalow RS (eds) Radioimmunoassay: methodology and applications in physiology and in clinical studies. Horm Metab Res [Suppl] 5: 162–166

    Google Scholar 

  • Laron Z, Pertzelan A, Karp M (1975) Glucose intolerance in children and young adults with dwarfism due to hGH deficiency and with the Syndrome of dwarfism and high plasma IR-hGH. In: Laron Z, Karp M (eds) Diabetes in juveniles, Modern Problems in pediatrics, vol 12. Karger, Basel London New York, pp 109–117

    Google Scholar 

  • Laron Z, Pertzelan A, Doron M, Assa S, Keret R (1977) The effect of dihydrosomatostatin in dwarfism with high plasma immunoreactive growth hormone. Horm Metab Res 9: 338–339

    Article  PubMed  CAS  Google Scholar 

  • Laron Z, Arad J, Gurewitch R, Grunebaum M, Dickerman Z (1980a) Age at first conscious ejaculation: a milestone in male puberty. Helv Paediatr Acta 35: 13–30

    PubMed  CAS  Google Scholar 

  • Laron Z, Kowadlo Silbergeld A, Eshet R, Pertzelan A (1980b) Growth hormone resistance. Ann Clin Res 12: 269–277

    PubMed  CAS  Google Scholar 

  • Laron Z, Sarel R, Pertzelan A (1980c) Puberty in Laron type dwarfism. Eur J Pediatr 134: 79–83

    Article  PubMed  CAS  Google Scholar 

  • Martin JB (1983) Neuroendocrine regulation of growth hormone secretion. In: Laron Z, Butenandt O (eds) Evaluation of growth hormone secretion, pediatric and adolescent endoerinology, vol 12. Karger, Basel

    Google Scholar 

  • McCoy EE, Bala RM (1978) Somatomedin deficiency (Laron type) dwarfism in Eskimo children ( Abstr. ). Clin Res 26: 845A

    Google Scholar 

  • Merimee TJ, Hall J, Rabinowitz D, McKusick VA, Rimoin DL (1968) An unusual variety of endoerine dwarfism: subresponsiveness to growth hormone in a sexually mature dwarf. Lancet II: 191-193

    Google Scholar 

  • Merimee TJ, Finberg SE, McKusick VA, Hall J (1970) Diabetes mellitus and sexual ateleiotic dwarfism: a comparative study. J Clin Invest 49: 1096–1102

    Article  PubMed  CAS  Google Scholar 

  • Moses AC, Nissley SP, Passamani J, White RM (1979) Further characterization of growth hormone-dependent somatomedin-binding proteins in rat serum and demonstration of somatomedin binding proteins produced by rat liver cells in culture. Endoerinology 104: 536–546

    Article  CAS  Google Scholar 

  • Najjar SS, Khachadurian AK, Ilbawl MN, Blizzard RM (1971) Dwarfism with elevated levels of plasma growth hormone. N Engl J Med 284: 809–812

    Article  PubMed  CAS  Google Scholar 

  • Nevo Z, Mimouni M, Laron Z (1977) Growth Parameters of cultured skin fibroblasts and growth promoting activity of sera from patients with growth disturbances ( Abstr. ). Isr J Med Sei 33: 1242

    Google Scholar 

  • Pertzelan A, Adam A, Laron Z (1968) Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone. Isr J Med Sei 4: 895–900

    CAS  Google Scholar 

  • Pierson M, Malaprade D, Fortier G, Belleville F, Lasbennes A, Wuilbercq L (1978) Le nanisme familial de type Laron, deficit gentique primaire en somatomedine. Arch Fr Pediatr 35: 151–164

    PubMed  CAS  Google Scholar 

  • Pombo JLH, Lozano I, Ruiz-Valdepenas MP, Arrieta F, Rodrigues-Minon JL (1973) Enanismo familiar com niveles elevados de STH immunoreactive. Rev Clin Esp 131: 149–152

    Google Scholar 

  • Posner BI, Kelly PA, Shin RPC, Frisen HG (1974) Studies of insulin, growth hormone and prolactin bin ding: tissue distribution, species Variation and characterization. Endocrinology 96: 521–531

    Article  Google Scholar 

  • Rappaport R, Czernichow P, Prevost C, Jullien M (1977) Retard de croissance avec somathoormone circulante elevee et incapacite ä generer la somatomedine (nanisme de type Laron). Ann Pediatr (Paris) 24: 63–67

    CAS  Google Scholar 

  • Root AW (1972) Human pituitary growth hormone. Thomas, Springfield, III, p 31 Saldanha PH, Toledo SPA (1981) Famüial dwarfism with IR-GH: Report of two affected sibs with genetic and epidemiologic considerations. Hum Genet 59: 367–372

    Google Scholar 

  • Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49: 825–836

    PubMed  CAS  Google Scholar 

  • Schalch DS, Heinrich UE, Draznin B, Johnson CJ, Müler LL (1979) Role of the liver in regulating somatomedin activity; hormonal effects on the synthesis and release of insulin like growth factor and its carrier protein by the isolated perfused rat liver. Endocrinology 104: 1143–1151

    Article  PubMed  CAS  Google Scholar 

  • Scharf A, Laron Z (1972) Skull changes in pituitary dwarfism and the Syndrome of familial dwarfism with high plasma immunoreactive growth hormone. A reontgenologic study. Horm Metab Res 4: 93–97

    Google Scholar 

  • Schoenle E, Zapf J, Humbel RE, Froesch ER (1982) Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 296: 252–253

    Article  PubMed  CAS  Google Scholar 

  • Shurka E, Laron Z (1975) Adjustment and rehabilitation problems of children and adolescents with growth retardation. I. Familial dwarfism with high plasma immunoreactive human growth hormone. Isr J Med Sei 11: 352–357

    Google Scholar 

  • Sneid DS, Jacobs LS, Weldon VV, Triveldi BL, Daughaday WH (1975) Radioreceptor inactive growth hormone associated with stimulated secretion in normal subjects. J Clin Endocrinol Metab 41: 471–474

    Article  PubMed  CAS  Google Scholar 

  • Van den Brande JL, DuCaju MVL, Visser HKA, Schopman W, Hacheng WHL, Degenhart HJ (1974) Primary somatomedin deficiency. Arch Dis Child 49: 297–304

    Article  PubMed  Google Scholar 

  • Zaizov R, Laron Z (1966) Body length and weight at birth and one year of age in different communities in Israel. Acta Paediatr Scand 55: 524–528

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pediatrics and Adolescent Endocrinology, Beilinson Medical Center, Petah Tikva, 49100, Israel

    Z. Laron

Authors
  1. Z. Laron
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

P. Frick G.-A. von Harnack K. Kochsiek G. A. Martini A. Prader

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Laron, Z. (1984). Laron-Type Dwarfism (Hereditary Somatomedin Deficiency): A Review. In: Frick, P., von Harnack, GA., Kochsiek, K., Martini, G.A., Prader, A. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics, vol 51. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69070-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69070-9_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69072-3

  • Online ISBN: 978-3-642-69070-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation